Schønheyder H C
Aalborg Sygehus, klinisk mikrobiologisk afdeling.
Ugeskr Laeger. 1994 Mar 28;156(13):1931-4.
Group A beta-haemolytic streptococci (GAS) have remained sensitive to penicillin, but penicillin V therapy does not eradicate GAS in 5-30% of cases of GAS tonsillitis. Multiple factors contribute to treatment failure, the foremost among these being lack of compliance with the prescribed therapy, tolerance of GAS towards the killing effect of penicillin, inactivation of penicillin by bacterial beta-lactamases, and absence of bacteriocin-producing non-haemolytic streptococci from the oral flora. The effect of local immunity should be further assessed. It is unlikely that environmental sources of GAS play any significant role. Throat cultures should not routinely be repeated after penicillin treatment. If, in special cases, a new course of treatment is indicated, penicillin V should still be preferred. In the light of modern pharmacological insights, multiple dosing schedules may be desirable in the therapy of GAS tonsillitis.
A组β溶血性链球菌(GAS)对青霉素仍敏感,但在5%至30%的GAS扁桃体炎病例中,青霉素V治疗无法根除GAS。多种因素导致治疗失败,其中最主要的是未遵医嘱治疗、GAS对青霉素杀菌作用的耐受性、细菌β-内酰胺酶使青霉素失活以及口腔菌群中缺乏产生细菌素的非溶血性链球菌。应进一步评估局部免疫的作用。GAS的环境来源不太可能起任何重要作用。青霉素治疗后不应常规重复进行咽喉培养。在特殊情况下,如果需要新的治疗疗程,仍应首选青霉素V。根据现代药理学见解,GAS扁桃体炎治疗中可能需要采用多次给药方案。